Probicient is a local food technologist company, a spin-off between National University of Singapore (NUS) Department of Food Science & Technology (FST) and Origgin Ventures, a specialist in early stage deep-tech start-ups and venture co-creation.
Our team has created the World’s First Probiotic Beer, as a healthier beer alternative can regulate immune system, neutralise toxins and viruses as well as enhance overall gut health. We pride ourselves in conducting continual innovations and clinical trials to enhance our functional beverage portfolios.
Bringing healthier yet still tasty beer drinking experience to the masses, one brewery at a time.
We are a technology-first company specialising in flavour, nutrition and advanced fermentation and probiotification techniques, providing value creation to breweries and microbreweries worldwide access to, and collaborations with our beverage innovation capabilities as the creators of the world’s first probiotic beer.
More than $1.5 million investment had been invested into research and development of this probiotic beer, which as pioneered by Associate Professor Liu Shao Quan and his research team from National University of Singapore (NUS) Department of Food Science & Technology (FST) through evidence-based research and clinical trials.
Thereafter, Probicient was founded as a spin-off between NUS-FST and Origgin Ventures, a specialist in early stage deep-tech start-ups and venture co-creation.
Probicient’s IP lies in its distinct pairing of unique strains and patented fermentation processes as the world’s first probiotics beer, a technological breakthrough that ensures the probiotics’ survivability of 1 billion CFU, together with its intrinsic antimicrobial compounds.
One billion CFU is the minimum amount considered to be an effective probiotic, according to ISAPP (International Scientific Association for Probiotics and Prebiotics). All our beers contain a probiotic cell count of over 1 billion per can.
Our patented probiotic beers were developed from lab-to-table moving from nascent stage, clinical trials to consumer test and are now ready for commercial scale-up to commercial breweries and micro-breweries around the world.